MSB 2.52% $1.16 mesoblast limited

DREAM HF Trial Video, page-4

  1. 413 Posts.
    lightbulb Created with Sketch. 11431
    To which Dr Perin adds “Hopefully you will be excited by what we are about to show”.

    I am sure Hector, Muffin et al, are all going to be delighted. I mean the preliminary data , was already groundbreaking ….so what could he be more excited about ?

    Hot Copper, we now have coming up within weeks the FDA decision on acceptance for 2-6 month review of the BLA resubmission (or not) . Then the number one cardiology journal in the world, JACC, will apparently publish on the 27th February, a detailed peer review of the most comprehensive mesenchymal cell Phase 3 RCT in history…which has already “gone to press” and for which we are told in the video (to the Global Cardiovascular Forum 2023) is something to read all about.

    I think I have got the hint . Have you ? A shorter known as Sore might wish to review “their” seating and market positions in due course. OP


    References regarding JACC paper at approx 1.25, 10.54 and 14.13. Enjoy !
    Last edited by otherperspective: 03/02/23
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.16
Change
-0.030(2.52%)
Mkt cap ! $1.370B
Open High Low Value Volume
$1.18 $1.22 $1.15 $4.160M 3.524M

Buyers (Bids)

No. Vol. Price($)
11 15914 $1.16
 

Sellers (Offers)

Price($) Vol. No.
$1.17 22355 8
View Market Depth
Last trade - 13.20pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.